A detailed history of Hfg Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Hfg Advisors, Inc. holds 2,660 shares of NVO stock, worth $270,628. This represents 0.29% of its overall portfolio holdings.

Number of Shares
2,660
Previous 2,660 -0.0%
Holding current value
$270,628
Previous $379,000 16.62%
% of portfolio
0.29%
Previous 0.37%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$122.71 - $146.91 $66,263 - $79,331
-540 Reduced 16.88%
2,660 $379,000
Q1 2024

Apr 18, 2024

SELL
$102.11 - $135.92 $12,865 - $17,125
-126 Reduced 3.79%
3,200 $410,000
Q4 2023

Jan 12, 2024

BUY
$87.78 - $105.45 $43,890 - $52,725
500 Added 17.69%
3,326 $344,000
Q3 2023

Oct 24, 2023

BUY
$90.94 - $199.54 $256,996 - $563,900
2,826 New
2,826 $256,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Hfg Advisors, Inc. Portfolio

Follow Hfg Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hfg Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hfg Advisors, Inc. with notifications on news.